Cited by 22Epilepsy research and treatmentGenetics and Neurodevelopmental DisordersTuberous Sclerosis Complex Research

Abnormal expression of cdk5 in focal cortical dysplasia in humans.

Sisodiya, Sanjay M, Thom, Maria, Lin, Woan-Ru, Bajaj, Narinder P.S, Cross, J.Helen, Harding, Brian N·2002·Neuroscience Letters

Abstract

Focal cortical dysplasia (FCD) is an important cause of refractory epilepsy in humans. The origin of its pathognomonic abnormal cell types and the links between abnormal cell morphology and epileptogenicity remain unknown. The developmentally-regulated kinase cdk5 and its neuronal activator p35 are known to be central to a number of key components in neuronal development, cellular morphology, cytoskeletal function, synaptic plasticity and neurodegeneration. Here we examine eight cases of human FCD for expression of cdk5. We show abnormal cdk5 immunoreactivity and aggregation of protein suggesting alterations in cdk5 may also be involved in this important epileptogenic human pathology.

Integrity signals

Registry

Crossref · 10.1016/s0304-3940(02)00520-7

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysplastic cortical neurons in focal cortical dysplasia patients express CDK5 aggregations.

    “and dysplastic cortical neurons in FCD patients express CDK5 aggregations (Sisodiya et al., 2002).”

    From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Sisodiya et al., 2002

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sisodiya, S. M., Thom, M., Lin, W.-R., Bajaj, N. P. S., Cross, J. H., & Harding, B. N.
Affiliations
  • National Hospital for Neurology and Neurosurgery (GB)
  • King's College London (GB)
  • Great Ormond Street Hospital (GB)
Corresponding author
Sisodiya, Sanjay M
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2002-08
Volume
328
Issue
3
Pages
217-220
ISSN
0304-3940 (ISSN-L)
OpenAlex
W1966222806
Cited by
22
References
1
Citations by year
2022: 1 · 2014: 1 · 2013: 1
FWCI
1.92
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience Letters (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Physiology › Tuberous Sclerosis Complex Research
Keywords
focal cortical dysplasia, cyclin-dependent kinase 5, p35, drug-resistant epilepsy, epileptogenicity, protein aggregation, neuronal development, cytoskeletal function, synaptic plasticity
MeSH terms
Congenital Abnormalities, Cerebral Cortex, Humans, Neurons, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase 5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review